期刊文献+

疏血通配合西药治疗脑梗死临床疗效研究

Clinical efficacy of Shuxuetong combined with Western medicine in the treatment of cerebral infarction
下载PDF
导出
摘要 目的观察疏血通配合西药治疗脑梗死的疗效。方法将100例脑梗死患者随机分组。对照组患者接受脑梗死西药常规治疗,研究组患者在此基础上接受疏血通治疗。对比两组患者总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)等血脂指标和临床疗效等方面的差异性。结果与对照组对比,研究组患者TC、TG、LDL-C明显较低;HDL-C明显较高,其中,研究组分别为(4.11±1.08)、(1.44±0.68)、(1.56±0.70)和2.05±0.41,对照组为(6.14±1.37)、(1.87±0.75)、(3.63±1.15)和(1.71±0.39)。研究组总有效率明显较高,研究组为96.0%,对照组为80.0%,差异有统计学意义(P<0.05)。结论采用疏血通配合西药治疗脑梗死可起到良好的调脂效果,改善脑梗死患者的神经功能。 [Abstrac] Objective To observe the curative effect of ShuXieTong cooperate with western medicine treatment of cerebral infarction. Methods 100 patients with cerebral infarction were randomly grouped. The control group patients with cerebral infarction of conventional western medicine therapy, observed group of patients were treated with ShuXieTong on the basis of the control group.Compared with total cholesterol(TC), triglyceride(TG), low density lipoprotein(LDL)-c), high-density lipoprotein(HDL- C) and other blood lipid index and the differences of clinical curative effect, etc of the two groups of patients. Results Compared with control group, the team patients was associated with significantly lower TC, TG, LDL- C; HDL- C significantly higher, of which,the team were(4.11±1.08),(1.44±0.68) and(0.68±0.70) and(0.70±0.41), the control group was(6.14 ±1.37),(1.87±0.75) and(0.75±1.15) and 1.15± 0.39. Group total effective rate significantly higher, the team was 96.0%, the control group was 80.0%, the difference was statistically significant(P〈0.05). Conclusion ShuXieTong cooperate with western medicine treatment of cerebral infarction can play a good effect of tiaozhi, improve neural function in patients with cerebral infarction.
作者 吕逸宁
出处 《中国卫生产业》 2014年第21期33-34,共2页 China Health Industry
关键词 疏血通 西药 脑梗死 ShuXieTong Western medicine Cerebral infarction
  • 相关文献

参考文献6

二级参考文献52

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部